Buprenorphine And Naloxone 62175-0458
Product NDC
62175-0458- Manufacturer
- Lannett Company, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 19, 2016
- Listing Expires
- December 31, 2027
- Application
- ANDA205022
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine | 8 mg/1 |
| Naloxone | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Opioid Antagonist [EPC]Opioid Antagonist [EPC]
Packaging Options(1)
30 TABLET in 1 BOTTLE (62175-458-32)